Alcon shares updates during AOA's Optometry's Meeting 2024

Alcon held a media briefing at the American Optometric Association’s (AOA) 2024 Optometry’s Meeting in Nashville.

Following are highlights from information shared during the briefing.

Dry eye
July is Dry Eye Awareness Month.

More than 30 million American suffer from dry eye.

Eyes face a world of challenges, such as:
• Longer busier days
• Environmental challenges
• Digital device dryness

You blink 60% less when staring at your screen.

Alcon is the title sponsor for TFOS DEWS III.

Contact lenses
Up to 58% of contact lens wearers experience symptomatic contact lens discomfort.

More than half of contact lens wearers wish they could wear their lenses longer each day.

About 50% of spectacle weaers are interested in contact lenses, but only 10% say their doctor brings up contact lenses during their exam.

About 54% of new contact lens fits are in a resuable contact lens.

Alcon’s Marlo app has been downloaded more than 20,000 times and is now available for Android phones.

Marlo offers:
• Seamless reoders
• Custom practice branding
• Vision screening
• Marlo Doctor Locator

Marlo’s ProPlus option costs $25 per month.

Allergy
Pataday outperforms Claritin and Flonase for ocular itch.

Pipeline
Alcon had more than 90 pipeline products under development in 2023, including 53 that have achieved positive proof of concent or are undergoing regulatory review.

Recent launches include:
• Eyesuvis (loteprednol etabonate 0.25%, acquired from Kala)
• Rocklatan (netarsudil 0.02%/latanoprost 0.005%, acquired from Aerie)
• Rhopressa (netarsudil 0.02%, acquired from Aerie)